Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice.

Bouchardy C, Queneau PE, Fioretta G, Usel M, Zellweger M, Neyroud I, Raymond L, de Wolf C, Sappino AP.

Br J Cancer. 2001 Nov 2;85(9):1251-7.

2.

Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.

Fata F, Mirza A, Craig G, Nair S, Law A, Gallagher J, Ellison N, Bernath A.

Cancer. 2002 Apr 1;94(7):1931-8. Review.

3.

Age and adjuvant chemotherapy use after surgery for stage III colon cancer.

Schrag D, Cramer LD, Bach PB, Begg CB.

J Natl Cancer Inst. 2001 Jun 6;93(11):850-7.

PMID:
11390534
4.

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.

Hershman D, Hall MJ, Wang X, Jacobson JS, McBride R, Grann VR, Neugut AI.

Cancer. 2006 Dec 1;107(11):2581-8.

5.

Adjuvant chemotherapy for stage II colon cancer: influence of care structures' characteristics on a controversial clinical practice.

Alter E, Phelip JM, Guilhot JN, Matysiak M, Vermorel M, Roblin X.

Eur J Gastroenterol Hepatol. 2007 Nov;19(11):995-1001.

PMID:
18049170
6.

Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practice.

Ananda S, Field KM, Kosmider S, Compston D, Desai J, Lim LC, Barnett FS, Jones IT, Skinner I, Gibbs P.

J Clin Oncol. 2008 Sep 20;26(27):4516-7; author reply 4517-8. doi: 10.1200/JCO.2008.18.7443. No abstract available.

PMID:
18802167
7.

Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer.

Earle CC, Weiser MR, Ter Veer A, Skibber JM, Wilson J, Rajput A, Wong YN, Benson AB 3rd, Shibata S, Romanus D, Niland J, Schrag D.

J Surg Oncol. 2009 Dec 1;100(7):525-8. doi: 10.1002/jso.21373.

PMID:
19697351
8.

Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.

Krzyzanowska MK, Regan MM, Powell M, Earle CC, Weeks JC.

J Am Coll Surg. 2009 Feb;208(2):202-9. doi: 10.1016/j.jamcollsurg.2008.10.016. Epub 2008 Dec 18.

PMID:
19228531
9.

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.

Gynecol Oncol. 2005 Mar;96(3):651-7.

PMID:
15721407
10.

Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.

Zuckerman IH, Rapp T, Onukwugha E, Davidoff A, Choti MA, Gardner J, Seal B, Mullins CD.

J Am Geriatr Soc. 2009 Aug;57(8):1403-10. doi: 10.1111/j.1532-5415.2009.02355.x. Epub 2009 Jun 25.

PMID:
19563521
11.

Patient age and cancer treatment decisions. Patient and physician views.

Kutner JS, Vu KO, Prindiville SA, Byers TE.

Cancer Pract. 2000 May-Jun;8(3):114-9.

PMID:
11898135
12.

Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.

Wu X, Chen VW, Andrews PA, Chen L, Hsieh M, Fontham ET.

J La State Med Soc. 2004 Sep-Oct;156(5):255-61.

PMID:
15554095
13.

Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study.

Sundararajan V, Grann VR, Jacobson JS, Ahsan H, Neugut AI.

Cancer J. 2001 May-Jun;7(3):213-8.

PMID:
11419029
14.

Adjuvant systemic therapies in patients with colorectal cancer: an audit on clinical practice in Italy.

Drug Utilization Review Team in Oncology.

Tumori. 2005 Nov-Dec;91(6):472-6.

PMID:
16457144
15.

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.

Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S; EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.

J Natl Cancer Inst. 2003 Jan 15;95(2):113-25.

PMID:
12529344
16.

Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces.

Wirtzfeld DA, Mikula L, Gryfe R, Ravani P, Dicks EL, Parfrey P, Gallinger S, Pollett WG.

Can J Surg. 2009 Apr;52(2):92-7.

17.

Survival and time interval from surgery to start of chemotherapy among colon cancer patients.

Zeig-Owens R, Gershman ST, Knowlton R, Jacobson JS.

J Registry Manag. 2009 Summer;36(2):30-41; quiz 61-2.

PMID:
19694115
18.

Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer.

Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI.

Ann Intern Med. 2002 Mar 5;136(5):349-57.

PMID:
11874307
19.

A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.

Phelip JM, Molinié F, Delafosse P, Launoy G, Trétarre B, Bara S, Buémi A, Velten M, Danzon A, Ganry O, Bouvier AM, Grosclaude P, Faivre J.

Gastroenterol Clin Biol. 2010 Feb;34(2):144-9. doi: 10.1016/j.gcb.2009.08.012. Epub 2010 Jan 15.

20.

Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.

Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL, Fuchs CS.

J Clin Oncol. 2006 Aug 1;24(22):3535-41. Epub 2006 Jul 5.

PMID:
16822843

Supplemental Content

Support Center